Principal Scientist, In Vivo Pharmacology, Neurology
Remote U.S. or Palo Alto, CA
About GondolaBio
GondolaBio is a clinical-stage biopharmaceutical company focused on developing breakthrough therapeutics for genetic diseases. GondolaBio is an independent sister company to BridgeBio, originally carved out in 2024 after securing $300M in private financing from external investors. GondolaBio aims to leverage cutting-edge biological research to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases.
Who You Are
You are an experienced in vivo pharmacology scientist with expertise in Neurology. You have demonstrated success in developing and/or applying in vivo disease models to drug discovery campaigns. You have extensive hands-on experience with rodent Neurology model characterization, test article dosing, tissue processing, and common wet lab techniques (e.g. qPCR, Western blot, ELISA). You are execution-oriented, capable of driving work through CROs and external partners, and thrive in a fast-paced biotech environment.
Key Responsibilities
Job details are sourced from the employer's original posting.
Open job postingAbout the company
This company is involved in clinical pharmacology and early clinical development, focusing on early clinical sciences and development strategy from first-in-human through Phase 2. They also lead quantitative sciences including data analytics, pharmacometrics, biostatistics, and data management to inform dose selection and program development.